Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Earnings drive big swings in European stocks ahead of Fed

Wed, 29th Jul 2020 09:50

(For a live blog on European stocks, type LIVE/ in an Eikon
news window)

* Investors await Fed, U.S. fiscal stimulus update

* Paris outperforms as Kering, Schneider earnings support

* Chemicals giant BASF slides as dividend under review
(Updates to market close)

By Sruthi Shankar

July 29 (Reuters) - Europe's main stocks benchmark closed
nearly flat on Wednesday, as investors waited to hear from the
U.S. Federal Reserve, but a flurry of earnings reports drove big
swings in individual stocks.

When the Fed concludes its monetary policy meeting later in
the day, investors are hoping that policymakers will reiterate
their accommodative stance to support financial markets as the
coronavirus pandemic takes its toll.

In a busy earnings day, the pan-European STOXX 600
closed down 0.1%, with healthcare and banks
dragging on the main index, while retailers jumped 1.4%.

Drugmaker GlaxoSmithKline fell 3.2% as it missed
second-quarter profit estimates after lower sales of its
existing vaccines, while lender Barclays dropped 6.1%
as it set aside a higher than expected 1.6 billion pounds ($2.1
billion) to cover a possible rise in loan losses due to the
pandemic.

The pair helped keep London's FTSE 100 nearly flat.

France's CAC 40 outperformed its continental peers
with a 0.6% rise after positive earnings updates from luxury
group Kering, electrical equipment group Schneider
Electric and consulting firm Capgemini.

"Markets have rallied aggressively, so what we're seeing is
companies coming with better numbers but not seeing an
additional uptick in markets," said Will James, deputy head of
European equities at Aberdeen Standard Investments.

"Companies that have managed earnings and sales, there have
been aggressive cost measures put in place."

Profits for STOXX 600 companies are expected to drop by a
record 59% in the second quarter, according to Refinitiv data.
But with much of the decline priced in, European stocks are on
course to end July with gains as investors bet on more stimulus.

Euro zone banks took a beating as Deutsche Bank
fell 2.5% after giving a slightly improved outlook
for the year, but chief executive Christian Sewing damped
speculation that the lender was eager to revive merger talks
with Commerzbank.

Spain's Santander slid 4.7% as it reported a record
net loss of 11.1 billion euros ($13 billion) in the second
quarter.

Chemicals giant BASF SE dropped 4.9% as it said
its dividend policy and the value of assets on its balance sheet
might be revised given uncertainty caused by the coronavirus
crisis.

UK retailer Next jumped 7.7% as it raised its profit
forecast after sales fell less than feared over the past three
months.
(Reporting by Sruthi Shankar in Bengaluru; Editing by Bernard
Orr and Uttaresh.V)

More News
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.